Jump to section

Billionbrains Garage Ventures (GROWW.NS) — Investment Thesis

Status: OWNED (2,298 shares, ₹3.53L invested, 35% of portfolio)

Quality Score: 19/25 (Grade B: Moderate Conviction)

Last Updated: 2026-03-11

Data Source: Screener.in (consolidated)

Quick Summary

One-line thesis: India's largest digital investment platform riding the structural shift in financial savings, with exceptional ROE (50%) and product optionality (AMC, MTF lending, personal loans) — but priced for perfection at 56x P/E.

Action: HOLD

Level	Price	Trigger
Buy / Add	₹120 – ₹145	DCF base case ₹74–₹97; P/B-ROE base (40% ROE) = ₹290 — add where DCF and P/B-ROE converge closer
Hold	₹145 – ₹190	Current range — 15–25% CAGR compounder; hold existing position
Sell / Exit	Above ₹190 or at trigger	ROCE drops below 30%; revenue growth falls below 15% YoY for 2 quarters

Why now (Mar 2026): Stock is at ₹155 (near mid-range of 52W ₹112–₹194), fairly valued for the compounder thesis. Position concentration (35% of portfolio) is the biggest concern — trim to 20–25% if a better-valued Grade A opportunity arises.

1. Business Summary

India's largest digital investment platform by active users on NSE. Offers stocks, derivatives, mutual funds, bonds, margin trading, and personal loans via a direct-to-customer model. Founded by ex-Flipkart employees. IPO in Nov 2025. The core thesis is India's massive underpenetrated financial services market being captured by a tech-first platform.

2. Quality Score

Dimension	Score (1-5)	Notes
MOAT	4	Network effects + brand in young India. 14M+ active users. But switching costs are low — users can easily move to Zerodha/Angel. MOAT is brand + UX, not structural.
Management	3	Founder-led (Lalit Keshre, ex-Flipkart). New as public company. Limited capital allocation track record. Promoter holding 27.8% — lower than ideal.
Financials	4	ROCE 62.6%, ROE 50%, net margin improving. Debt minimal (₹367Cr vs ₹7,356Cr equity). FY25 revenue ₹4,061Cr, profit ₹1,824Cr.
Growth Runway	5	India fintech TAM is massive. Mutual fund penetration <5%, demat accounts ~10% of population. 3Y sales CAGR 112%. TTM growth 45%.
Valuation	3	P/E 61 (consolidated) is expensive. Forward P/E ~34 if growth sustains. PEG ~0.5 which is attractive. But priced for perfection.
Total	19/25	Grade B: Moderate Conviction

3. Why This Could Be a Multi-Bagger

Catalyst 1: India demat account explosion. ~15Cr demat accounts for 140Cr population (~10%). If this doubles in 5 years, Groww captures disproportionate share as largest platform.
Catalyst 2: Revenue diversification. Currently broking-heavy. MF distribution, lending (personal loans), and margin trading are higher-margin, recurring revenue.
Catalyst 3: Operating leverage. Platform costs are largely fixed. OPM went from -55% (FY22) → 62% (FY25).
Catalyst 4: Young user base. Average Groww user is 25-30 years old. Lifetime value is very high as AUM compounds over decades.

Product Optionality — What Could Sustain ROE

Product	Current Status	Potential Revenue Contribution (FY28E)	Margin Profile
Broking (F&O + equity)	Core, ~70-75% revenue	₹3,500 Cr (slows as market matures)	Medium (regulatory risk)
MF Distribution	Growing, ~10-15%	₹800 Cr (CAGR 25%+ as SIP AUM compounds)	High (trail commission, recurring)
MTF (Margin Trading)	Scaling, ~5-8%	₹600 Cr (interest income, ~18-20% yield)	Very high (lending spread)
Personal Loans	Early stage	₹400 Cr (if book reaches ₹2,000 Cr)	High (watch NPA risk)
Own AMC (Groww MF)	Nascent	₹200 Cr long-term	Very high (AUM trail)

Key insight: If MTF + MF + loans together reach 40-45% of revenue by FY28 (vs ~25% today), ROE can sustain 40%+ even as broking margin pressure mounts. This is the bull case.

4. Key Metrics (Consolidated)

Metric	FY23	FY24	FY25	TTM (Dec 25)
Revenue (Cr)	1,142	2,794	4,061	~4,164
Net Profit (Cr)	458	(805)*	1,824	~1,596
OPM %	35%	27%	62%	~55%
ROCE %	—	63%	62.6%	—
ROE %	—	—	50%	—
Debt/Equity	~0	~0	0.13	0.05
Promoter %	—	—	27.81%	27.81%
P/E	—	—	—	61

FY24 loss due to one-time ESOP/listing costs. Underlying business was profitable.

Quarterly Trend (Consolidated, Cr)

Quarter	Revenue	Net Profit	OPM %
Sep 2024	1,125	420	49%
Dec 2024	975	757	104%**
Jun 2025	904	378	53%
Sep 2025	1,019	471	59%
Dec 2025	1,216	547	59%

*Dec 2024 had negative expenses (likely reversal/adjustment).

5. Valuation

Current Price: ₹155 (updated Mar 2026)
Market Cap: ₹95,728 Cr
P/E (Consolidated): 56x TTM | 34x Forward
P/B: 12.6x | Book Value: ₹12.3/share
ROE: 50% | ROCE: 62.6%
52-week range: ₹112 – ₹194

Peer Comparison: GROWW vs Angel One

Metric	GROWW	Angel One	GROWW Premium/Discount
P/E (TTM)	56x	27x	+107% premium
P/B	12.6x	3.4x	+270% premium
Revenue Growth (YoY)	25.8%	2.5%	GROWW 10x faster
Op Margin	58%	31%	GROWW superior
Net Margin	42%	17%	GROWW superior
Market Cap (Cr)	₹95,728	₹19,866	GROWW 5x larger

Interpretation: GROWW trades at a steep premium to Angel One but deserves it — 10x higher revenue growth and nearly double the operating margin. The premium is justified only if GROWW sustains its growth advantage. If GROWW's growth converges toward Angel One's 2.5%, the premium will collapse.

Model 1: DCF (Discounted Cash Flow)

Base FCF: ₹1,824 Cr (FY25 net profit) | Discount rate: 12% | Terminal growth: 5% | Shares: 628 Cr

Scenario	Growth Rates (5yr)	Fair Value	vs ₹157
Bear	15%→6% declining	₹55	-65%
Base	25%→12% declining	₹74	-53%
Bull	35%→15% declining	₹97	-38%

Reverse DCF: Market is pricing in 39% FCF CAGR for 5 years. That's aggressive.

Model 2: P/B-ROE (Justified Price-to-Book)

Book Value: ₹11.9 | Cost of Equity: 12%

Scenario	Sustainable ROE	Justified P/B	Fair Value	vs ₹157
Bear	25% (ROE halves)	4.2x	₹51	-68%
Base	40% (moderate decline)	24.3x	₹290	+84%
Bull	50% (current ROE holds)	32.7x	₹389	+148%

Implied ROE: At P/B 13.2x, market implies GROWW sustains 36% ROE. Current ROE is 50%.

Why the Two Models Disagree

Says	Overvalued	Undervalued (if ROE sustains)
Reason	Skeptical of high growth sustaining	Rewards high ROE businesses
Key assumption	FCF growth declines to 12-15%	ROE stays 40%+

The real question is: can GROWW sustain 40%+ ROE as book value grows?

Platform businesses can (low capital needs, high margins) → supports P/B-ROE view
But broking is cyclical, and competition erodes ROE over time → supports DCF caution
Product optionality (own AMC, MTF lending, personal loans) could sustain ROE by adding high-margin revenue streams

P/E Fair Value (simple)

Scenario	P/E	Profit (Cr)	Price	vs Current
Bear	30x	2,000 (FY27)	₹96	-39%
Base	40x	3,000 (FY27)	₹192	+22%
Bull	50x	4,000 (FY27)	₹320	+104%

Unrealistic at ₹157 entry. Would need 120x P/E or 50%+ CAGR sustained — bubble territory. This is a 15-25% CAGR compounder if ROE sustains, not a 5x from here.

6. Risks

Risk	Probability	Impact	Mitigation
SEBI tightens F&O rules, reducing volumes	High	Medium	Diversifying into MF, lending
Zerodha/Angel One eroding market share	Medium	Medium	Brand + UX, but low switching costs
Promoter holding dilution (27.8% already low)	Medium	Low	Watch lockup expiry
Market downturn — broking is cyclical	Medium	High	Bear market = revenue drops sharply
Lending NPAs as personal loan book scales	Low (early)	Medium	Book is small, monitor quarterly

7. Exit Triggers

[ ] ROCE drops below 30% for 2 consecutive quarters
[ ] Revenue growth declines to <15% YoY for 2 quarters
[ ] Promoter holding drops below 20%
[ ] Major SEBI action structurally damaging broking economics
[ ] Management governance red flags

8. Review Schedule

Next quarterly check: Q4 FY26 results (April/May 2026)
Key events to watch:
SEBI F&O regulation updates
Quarterly active user numbers
Lending book growth and NPA ratios
Promoter lockup expiry dates

9. Decision History

Date	Action	Price	Quantity	Reasoning
Multiple	BUY	₹153.78 avg	2,298	India fintech growth, largest platform by active users

10. Position Sizing Concern

35% of portfolio in one stock is very concentrated. Analysis shows:

This is a Grade B (not A) conviction stock
Valuation analysis: 15-25% CAGR story, not a 5x multi-bagger at current price
Consider: Trim to 20-25% and redeploy into higher-conviction, cheaper multi-bagger candidates

11. Comparison: GROWW vs ICICIAMC

Should you hold GROWW or swap for ICICIAMC? See dedicated analysis: research/GROWW_vs_ICICIAMC.md

Key takeaway: ICICIAMC is Grade A (21/25) with proven ROE sustainability. GROWW is Grade B (12/25) with unproven 40%+ ROE durability. The allocation (₹3.53L GROWW vs ₹13K ICICIAMC) is inverted relative to quality.

12. Research Log

New learnings, commentary, and thesis updates — most recent first.

Full edit history: git log research/GROWW.md

2026-03-12 — v2: Peer comparison + product optionality modeling

Added Angel One peer comparison: GROWW at 2x P/E premium but 10x the revenue growth
Premium is justified today; collapses if growth decelerates to peer levels
Modeled 5 product lines individually: MTF + MF distribution + loans = key to sustaining ROE
Earnings growth showing -34.1% YoY (yfinance) likely due to Dec 2024 exceptional item reversal — underlying growth intact at 25%+ revenue
Updated price to ₹155 (from ₹157). Stance unchanged: 15-25% CAGR compounder, not a 5x

2026-03-11 — Initial thesis created

Built 3-model valuation: DCF (bearish), P/B-ROE (bullish if ROE sustains), P/E (middle)
Key insight: DCF and P/B-ROE disagree. The thesis hinges on whether 40%+ ROE can sustain
Product optionality (own AMC, MTF, personal loans) is the bull case for sustained ROE
Position sizing concern flagged: 35% is too concentrated for Grade B conviction
Quality Score: 19/25 (Grade B). MOAT 4, Management 3, Financials 4, Growth 5, Valuation 3